Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P17174 (aspartate aminotransferase)
 14,872 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The pyridoxal form of the alpha subform of cytosolic aspartate aminotransferase (EC 2.6.1.1) is fully active and binds pyridoxal 5'-phosphate via an aldimine formation with Lys-258 whereas the gamma subform is virtually inactive and lacks the aldimine linkage. Comparison of 1H NMR spectra between the alpha and gamma subforms suggested that peak 1 of the alpha subform at 8.89 ppm contains a resonance assignable to the internal aldimine 4'-H. Reaction with a reagent that cleaves or modifies the internal aldimine bond [(amino-oxy)acetate, L-cysteinesulfinate, NH2OH, NaBH4, or NaCNBH3] caused the disappearance of a resonance line at 8.89 ppm that possessed a broad line width and corresponded in intensity to a single proton. These reagents were also used successfully for the identification of the aldimine 4'-H resonance in the mitochondrial isoenzyme. In contrast to the cytosolic isoenzyme whose resonance for the 4'-H did not show any detectable change in chemical shift with pH, the corresponding resonance in the mitochondrial isoenzyme exhibited pH-dependent chemical shift change (8.84 ppm at pH 5 and 8.67 ppm at pH 8) with a pK value of 6.3, reflecting the interisozymic difference in the microenvironment provided for the internal aldimine. Validity of the signal assignment was further shown by the two findings: the resonance assigned to the 4'-H emerged upon conversion of the pyridoxamine into the pyridoxal form, and the resonance appeared upon reconstitution of the apoenzyme with [4'-1H]pyridoxal phosphate but not with [4'-2H]pyridoxal phosphate.
 ...
PMID:Identification of coenzyme aldimine proton in 1H NMR spectra of pyridoxal 5'-phosphate dependent enzymes: aspartate aminotransferase isoenzymes. 370 19

In order to determine the ionization state of the 5'-phosphate of bound pyridoxal phosphate, a Fourier transform infrared spectroscopic study of cytosolic aspartate aminotransferase has been carried out. Dianionic and monoanionic phosphate monoesters give rise to two bands each in the infrared spectrum [Shimanouchi, T., Tsuboi, M., & Kyogoku, Y. (1964) Adv. Chem. Phys. 8, 435-498]. These bands can be identified in infrared spectra of the free coenzyme in solution. Due to interfering bands arising from the protein, only the band assigned to the symmetric stretching of the dianionic phosphate is observed in holoenzyme solutions. The integrated intensity of this band does not change with pH in the range 5.3-8.6, while for free pyridoxal phosphate, the integrated intensity of the same band changes with pH according to the pK value expected for the 5'-phosphate group in solution. Moreover, the value of the integrated intensity for the bound cofactor is close to the value given by free cofactor at pH 8-9. These results suggest that the 5'-phosphate of the bound cofactor remains mostly dianionic throughout the investigated pH range and disfavor other interpretations in terms of ionization of the phosphate group on the basis of the nuclear magnetic resonance 31P chemical shift-pH titration curve of holoenzyme [Schnackerz, K. D. (1984) in Chemical and Biological Aspects of Vitamin B6 Catalysis (Evangelopoulos, E. A., Ed.) Part A, pp 195-208, Alan R. Liss, New York].(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Ionization state of the coenzyme 5'-phosphate ester in cytosolic aspartate aminotransferase. A Fourier transform infrared spectroscopic study. 371 29

Mitochondrial aspartate aminotransferase is synthesized on free polysomes as a higher molecular weight precursor (Sonderegger, P., Jaussi, R., Christen, P., and Gehring, H. (1982) J. Biol. Chem. 257, 3339-3345). The present study examines whether the coenzyme pyridoxal phosphate or pyridoxamine phosphate is required for the uptake of the precursor into mitochondria. Chicken embryo fibroblasts were cultured in medium prepared with and without pyridoxal. In cells grown in the presence of pyridoxal only holoform of aspartate aminotransferase and no apoenzyme was detected. Cells cultured under pyridoxal deficiency contained about 30% of apoenzyme in secondary cultures. All of this apoform was identified as mitochondrial isoenzyme. In order to differentiate whether this apoenzyme corresponded to newly synthesized protein or originated from pre-existing holoenzyme, double isotope-labeling experiments were performed. Secondary cultures of chicken embryo fibroblasts grown under pyridoxal depletion were labeled with [3H]methionine, and then pulsed with [35S]methionine. In another series of experiments, the 3H-labeled cells were pulsed with [35S]methionine in the presence of the protonophore carbonyl cyanide m-chlorophenylhydrazone in order to accumulate the precursor. Subsequently, the accumulated precursor was chased into the mitochondria by addition of the carbonyl cyanide m-chlorophenylhydrazone antagonist cysteamine. The holo- and apoenzyme from the ultrasonic extract of the double-labeled cells were separated by affinity chromatography on a phosphopyridoxyl-AH-Sepharose column, immunoprecipitated, and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography. Under both experimental conditions, the 3H/35S ratio of the apoenzyme was less than half of that of the holoenzyme. Therefore, the apoenzyme and not the holoenzyme is the first product of the precursor in the mitochondria. Apparently, the precursor of mitochondrial aspartate aminotransferase is transported into mitochondria as apoprotein and is processed there independently of the coenzyme.
 ...
PMID:The precursor of mitochondrial aspartate aminotransferase is translocated into mitochondria as apoprotein. 373 49

The streptozotocin diabetic rat was selected as a model to study how insulin deficiency alters vitamin B6 utilization by focusing on pyridoxal phosphate levels and aspartate aminotransferase activities in liver tissues. Diabetes of 15 weeks' duration lowered plasma pyridoxal phosphate levels by 84%. Normal plasma pyridoxal phosphate was 480 pmole/ml. Fractionation of liver into mitochondrial and extramitochondrial compartments demonstrated that diabetes caused a 43% diminution in mitochondrial pyridoxal phosphate per gram of liver. There was no cytoplasmic change in these diabetic rats. Mitochondrial aspartate aminotransferase activity was decreased 53% per gram of diabetic liver and cytoplasmic aspartate aminotransferase activity was elevated 3.4-fold. Damage to diabetic mitochondria during preparation procedures could not account for the rise in cytoplasmic aspartate aminotransferase activity. Electrophoresis showed that in the diabetic cytoplasm both cathodal and anodal forms of the enzyme were elevated. Speculations concerning mitochondrial loss and cytoplasmic gain of enzyme activity as well as those on the reduction of plasma pyridoxal phosphate in the diabetic rat are presented.
 ...
PMID:Experimental diabetes causes mitochondrial loss and cytoplasmic enrichment of pyridoxal phosphate and aspartate aminotransferase activity. 374 6

The storage stability of the catalytic activity of aspartate aminotransferase (AST) remains the subject of conflicting reports. We reevaluated this issue for total AST activity and for the cytosolic and mitochondrial isoenzymes from human sera stored at room, refrigerator, and freezer temperatures for up to 28 days. We found that these enzymes were stable for catalytic activity and immunologic (mass) measurements up to 24 hours at ambient temperatures and for at least 28 days at 4 degrees, -20 degrees, and -80 degrees C. The addition of exogenous pyridoxal phosphate (0.1 mmol/L) to serum improved stability of AST storage at ambient temperature (22 degrees C) from 1 day to 7 days.
 ...
PMID:Serum aspartate aminotransferase storage and the effect of pyridoxal phosphate. 377 27

1-Aminooxy-3-aminopropane was shown to be a potent competitive inhibitor (Ki = 3.2 nM) of homogenous mouse kidney ornithine decarboxylase, a potent irreversible inhibitor (Ki = 50 microM) of homogeneous liver adenosylmethionine decarboxylase and a potent competitive (Ki = 2.3 microM) of homogeneous bovine brain spermidine synthase. It did not inhibit homogeneous bovine brain spermine synthase and it did not serve as a substrate for spermidine synthase. The compound did not inhibit tyrosine aminotransferase, alanine aminotransferase or aspartate aminotransferase, which are pyridoxal phosphate-containing enzymes like ornithine decarboxylase. The inactivation of adenosylmethionine decarboxylase was partially prevented by pyruvate, which is the coenzyme of adenosylmethionine decarboxylase, and by the substrate, adenosylmethionine. 1-Aminooxy-3-aminopropane at 0.5 mM concentration inhibited the growth of HL-60 promyelocytic leukemia cells and this inhibition was prevented by spermidine but not by putrescine.
 ...
PMID:1-Aminooxy-3-aminopropane, a new and potent inhibitor of polyamine biosynthesis that inhibits ornithine decarboxylase, adenosylmethionine decarboxylase and spermidine synthase. 386 Nov 82

The gene for aspartate aminotransferase from E. coli (aspC) was subcloned into M13 phage and sequenced using the Sanger dideoxy method with synthetic oligonucleotide primers. A mutant gene was constructed using site-directed mutagenesis techniques in which the codon for the lysine that forms the Schiffs base with pyridoxal phosphate was replaced with one coding for alanine. The mutant gene was expressed under control of the Tac promoter to overproduce a mutant protein lacking enzymatic activity.
 ...
PMID:Site-directed mutagenesis of aspartate aminotransferase from E. coli. 390 32

Riboflavin and vitamin B6 status of low-income mothers in Hyderabad, India, were assessed by erythrocyte glutathione reductase activation and erythrocyte aspartate aminotransferase activation tests, respectively, at different stages of lactation. Levels of these vitamins in milk also were measured. The 134 lactating women, who attended a maternal and child care clinic in a government hospital, were divided according to the duration of lactation into the following 6 groups: less than 5 days (Group I), 6-30 days (Group II), 1-6 months (Group III), 7-12 months (Group IV), 13-18 months (Group V), and more than 18 months (Group VI). 6 women had been using oral contraceptives (OCs) for 3-6 months (Group VII). Since OCs are not prescribed before 8 months of lactation, the lactational status of the OC users was comparable to that of the women in groups IV or V. Except for the pariurient mothers (Group I) who delivered in the hospital, the remainder of the women came to the hospital for routine pediatric care or contraceptive advice. Most women had had a frugal breakfast and had nursed their infants 2 hours prior to the sampling of blood and milk. 10 ml samples of foremilk (5 ml from each breast) were collected by manual expression. Samples of venous blood were draw after collecting the milk. Correlations between the maternal vitamin status and milk vitamin concentration were assessed by Pearson's correlation coefficient and frequency distribution. The majority of the women had biochemical evidence of riboflavin and pyridoxine deficiency, the incidence of the former being greater than the latter. Prolonged lactation did not worsen the vitamin status. Group II women showed a reduction in erythrocyte glutathione reductase activity (EGR-AC) values suggesting better riboflavin status than the other groups. A similar trend was not seen with regard to pyridoxal phosphate. Milk riboflavin concentration was similar in all the groups except Group II where the levels were significantly higher. Milk pyridoxine concentration increased 3-4 fold after 1 month of lactation and continued to be at that level beyond 18 months. There was no correlation between the maternal riboflavin and milk riboflavin status or maternal pyridoxine and milk pyridoxine status. The higher milk riboflavin concentration among the Group II women was seen regardless of the women's riboflavin status in that group. OC-treated women did not show any significant deviations from women not using OCs.
 ...
PMID:Relationship between maternal vitamins B2 and B6 status and the levels of these vitamins in milk at different stages of lactation. A study in a low-income group of Indian women. 395 16

The spatial structure of cytosolic chicken aspartate aminotransferase (AAT) has been determined by X-ray crystallographic analysis at 2.8 A resolution. AAT consists of two chemically identical subunits. Each subunit can be subdivided into the large pyridoxal phosphate (PLP) binding domain and the small domain. The two active sites of AAT are situated in deep clefts at the subunit interface. The binding of PLP and 2-oxoglutarate is described. Conformations of the following enzyme forms have been compared by difference Fourier syntheses: the nonliganded PLP-form in phosphate and acetate buffers; the non-liganded pyridoxamine phosphate (PMP) form; complexes of the PLP-form with glutarate and 2-oxoglutarate. Lattice-induced dynamic asymmetry of the dimeric AAT molecules was revealed. In one subunit the small domain is mobile and shifted either toward the active site ("closed" conformation) or in the opposite direction ("open" conformation). The closed conformation is induced by the binding of dicarboxylate anions. In the second subunit the small domain is immobile and shifted toward the active site in all enzyme forms or complexes studied. In this subunit, there occurs a rotation of the PLP ring by approximately 20 degrees toward the substrate site. The rotation is observed when crystals are soaked in 0.6 saturated (NH4)2SO4 solution buffered with 0.3 M potassium phosphate, pH 7.5; it was explained by formation of an external aldimine between PLP and NH3. This aldimine is not formed in the presence of dicarboxylates or acetate. It was inferred that dicarboxylate or acetate anions stabilize the internal PLP-lysine aldimine and prevent its reaction with ammonia. Conversion of AAT from the PLP- to PMP-form is accompanied by rotation of the coenzyme ring by approximately 20 degrees; the rotation occurs in both subunits.
 ...
PMID:[Cytosol aspartate aminotransferase from the chicken heart: three-dimensional structure at 2.8 angstroms resolution and the characteristic conformation of various enzyme forms]. 398 8

Both cytosolic and mitochondrial aspartate transaminase can be resolved of pyridoxal phosphate. The resulting apoenzymes still bind individual structural components of the coenzyme. The separate contributions of coenzyme components to protein thermal stability have been independently assessed for phosphate ions (Pi) and for the pyridoxal or pyridoxamine components of the coenzyme. 31P NMR and differential scanning calorimetry reveal that the thermodynamic contributions of binding are not additive and are dissimilar for the two isozymes. High and low affinity sites for Pi binding are present in both apoenzymes with only the low affinity site being present in the holoenzyme forms. The contribution of both bound phosphates to increasing temperatures (Tm) and enthalpies (delta Hd) of denaturation differ between the isozymes and within sites. In either isozyme occupancy of the high affinity site by Pi produces only a 4- or 5- degree increase in the Tm value with respect to Pi-free apoenzyme. By contrast, in the mitochondrial apoenzyme, the presence of Pi at the second low affinity site increases the calorimetric parameters from Tm = 47 degrees C and delta Hd = 4.7 cal g-1 to Tm = 62 degrees C and delta Hd = 7 cal g-1. For cytosolic apoenzyme the respective changes are from 66 to 69.5 degrees C and 5.2 to 5.8 cal g-1. Addition of pyridoxal, but not pyridoxamine, displaces the high affinity Pi in both apoenzymes. This shows that the pyridine ring and Pi groups of pyridoxal-P bind exclusive of each other when they are not covalently linked as an ester, as in the coenzyme. The observation has been exploited as a method to prepare completely dephosphorylated mitochondrial apoenzyme. Electrostatic effects, structural differences in the phosphate binding pockets, and steric effects can be invoked to account for the Pi and pyridine binding behavior in the two proteins.
 ...
PMID:The separate effects of coenzyme components may not be additive. Roles of pyridoxal and inorganic phosphate in aspartate aminotransferase apoenzymes. 399 81


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>